Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|April 17, 2023
Case report: Obstructive jaundice caused by biliary cystadenomaYun-Cheng Li, An-da Shi, Kang-Shuai Li
Genes & Diseases|September 5, 2020
Adjuvant therapies after curative treatments for hepatocellular carcinoma: Current status and prospectsXiao-Dong Zhu, Kang-Shuai Li, Hui-Chuan Sun
Frontiers in Oncology|December 26, 2022
Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysisKang-Shuai Li, Sen Guo, Yu-Xin Chen, et al.
Frontiers in Pharmacology|December 3, 2024
Protocol of REACH-01: a single-arm, open label, prospective study of HAIC sequential TAE combined with tislelizumab and surufatinib in unresectable intrahepatic cholangiocarcinomaKang-Shuai Li, Yi Liu, Tie-Zhong Zhang, et al.
World Journal of Surgical Oncology|February 3, 2026
ERBB2 I655V mutation correlates with efficacy of immunotherapy in gallbladder cancerQiang Gao, Ying-Nan You, Shuo Lian, et al.
Journal of Cellular and Molecular Medicine|July 25, 2023
SMAD4 regulates the progression of cholangiocarcinoma by modulating the expression of STING1An-da Shi, Li-Ming Zhao, Guo-Li Sheng, et al.
Annals of Translational Medicine|February 12, 2020
Renin-angiotensin inhibitors were associated with improving outcomes of hepatocellular carcinoma with primary hypertension after hepatectomyLong-Hai Feng, Hui-Chuan Sun, Xiao-Dong Zhu, et al.
Frontiers in Pharmacology|September 5, 2024
Prognostic nomogram for patients with advanced unresectable hepatocellular carcinoma treated with TAE combined with HAICLi-Xin Du, Guo-Li Sheng, An-da Shi, et al.
Experimental Hematology & Oncology|April 5, 2022
Physical activity improves outcomes of combined lenvatinib plus anti-PD-1 therapy in unresectable hepatocellular carcinoma: a retrospective study and mouse modelXue-Feng Liu, Xiao-Dong Zhu, Long-Hai Feng, et al.
Annals of Translational Medicine|March 12, 2021
Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinomaLong-Hai Feng, Hui-Chuan Sun, Xiao-Dong Zhu, et al.
Pageof 3